RE:RE:RE:RE:RE:RE:RE:RE:TH is dead money The situation with CYDY pretty much invalidates your position that a company needs to have dat, etc., in order for the stock to be valued fairly. And it's not just CYDY, there are many, many less exreme examples of companies that have far less than THTX yet are valued at much higher levels. It may be crazy, but it is what is going on right now in this bubble. The oddity is that it is not happening to THTX too.
jfm1330 wrote: You said it, convinced, but how? CYDY did not educated any investor, they simply BSed them. They pumped their monoclonal antibody like crazy for everything without any proof of anything of commercial value. It is like this thing is a cure all miracle. Hard to understand so many people are putting so much money in it. But it is the USA... Their best case scenario is to be approved for MDR HIV after Trogarzo and Rukobia, and only good for CCR5 patients. Huge market to capture, to say the least...
scarlet1967 wrote: That is my exact point we don't need more advanced science we need people to understand it and understand the financial of it so they invest in it. Not every retail investors have scientific background yet companies like Intercept and CYDY have managed to convince and educate their investors with inferior products this was one of my main arguments with Leah and she sort of agreed, I understand why she didn't fully agreed cause she has more than twenty years of marketing and it's hard to take advice with that background, but those experiences are from well known big pharmaceutical companies so the marketing strategies for a well followed company won't work for a small biotech in Canada.
jfm1330 wrote: There is enough on Thera's website to know what the company is doing and to understand the general principles behind their clinical programs. Sorry, but if you don't have the proper scientific background, more advanced scientific explainations won't be understandable. I don't want to look more intelligent than anybody by saying that, it is just a matter of mastering enough pertinent scientific principles, and if you do, you can do your own litterature review to further understand what they are doing and where it stands in the larger context, including possible competition, odds of success based on history, etc....
scarlet1967 wrote: I was asked on Stocktwits from a share holder whether the company reverse fibrosis or not?
Shareholder there are asking what NASH means?
Shareholders there ask where they can find company's investor presentation on the website and when the find it they can't understand it?
Other comparable companies have much higher followers on Twitter, Stocktwits, yahoo finance chat sector and even on this MB!
The company is definitely unknown and certainly not understood.